According to Atai Life Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1135.64. At the end of 2023 the company had a P/S ratio of 745.
Year | P/S ratio | Change |
---|---|---|
2023 | 745 | -60.8% |
2022 | > 1000 | 3068.41% |
2021 | 60.0 |